Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
Clinical trial NCT01191034 · TERMINATED
Trial details
- NCT number
- NCT01191034
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-08-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.